Letrozole
NDC 80005-139, Letrozole, tablet, film coated, from Carnegie Pharmaceuticals LLC.
- Product NDC
- 80005-139
- Status
- Listed
- Labeler
- Carnegie Pharmaceuticals LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091191
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80005-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LETROZOLE2.5 mg/1
Pharmacologic classes
Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80005-139-08 | 80005013908 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80005-139-08) |
| 80005-139-10 | 80005013910 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (80005-139-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cb1da0ac-8db1-4482-824d-430511d1b7a0
Use it
Look up 80005-139 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80005-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80005-139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.